Clinical Trials on C3PI Study Testing Group in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
- Yantai Yuhuangding Hospital，Medical College, Qingdao University
- Prestige Biopharma Limited
- InflaRx GmbH
- Chengdu Nuoen Biotechnologies, Inc.
- BayCare Health System
- Grand Challenges Canada
- Reina Sofia University Hospital
- Bjørgene Omsorgssenter, Haugesund
- Centro di Procreazione Assistita Demetra
- Maria Lendorf
- Bruce County Paramedic Service
- ImproveCareNow (ICN)
- Veeda Oncology
- Neuregenix
- Women and children's hospital of Jiaxing university
- AIDS Council of New South Wales
- Equipe MiMes
- North Karelia Hospital District
- Mononuclear Therapeutics Ltd.
- Nestor Soler Porcar, MD, PhD
- View Full List
Medical Conditions
- Endocarditis Infective
- Chlamydophila Infections
- Childhood Langerhans Cell Histiocytosis
- Spine Surgeries
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Fracture Dislocation of Cervical Spine
- Multisystem Proteinopathy
- Gullian Barre Syndrome
- Psoriasis, Arthritic
- Fetus or Neonate Affected by External Version Before Labor
- Tay-Sachs Disease Ganglioside
- Epidemic Hemorrhagic Fever
- Pulmonary Adenocarcinoma
- Ewing's Family Tumors
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Predictors of Atrial Fibrillation Recurrences
- Closure; Foramen Ovale
- Skull Base Neoplasms
- Painless Hysteroscopy
- View Full List
Drug Interventions
- Adapalene Gel 0.3%
- Azelastine hydrochloride (BAYR9258)
- Cereport
- High dose pantoprazole infusion
- Palliative care group first-line scheme
- Qingkailing injection 40 ml
- Redifferentiation with retinoid acid
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Semapimod
- Vehicle
- Neihulizumab
- EFV +TVA
- Esomeprazole 40mg before
- Estradiol+Drospirenone
- Glimepiride
- Adriamycin
- Chemotherapeutic Agent
- View Full List
CROs by country
- Contract Research Organizations in Belgium
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Israel
- Contract Research Organizations in Japan
- Contract Research Organizations in Jordan
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mexico
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Romania
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Togo
- Contract Research Organizations in Uganda
- CRO list by country